Banner Year for Roadkill and Fernhill Beverage, Inc.
Carlsbad, CA -- January 4, 2017 -- InvestorsHub NewsWire -- Fernhill Beverage, Inc. (OTC Pink: FHBC) would like to thank all who participated in the launch of Roadkill Vitamin Packed drink in 2016.
Acceptance of the entry into the youth beverage market exceeded the Companys expectations. Revenues for the exciting new brand will nearly double initial estimates. The initial Spring launch consisted of 3 flavors. The flavors are Green Gopher Guts (Green Apple), Blue Raccoon Bits (Blue Raspberry) and Purple Possum Parts (Grape). A fourth flavor Red Fox In A Box (Fruit Punch) was added late in the third Quarter. A fifth flavor Yellow Chicken Chunks (Lemon Lime) is scheduled to be released in Spring 2017.
Roadkill will be receiving a Big Brother in early 2017. Roadkill XL-XF (Roadkill Extra Large, Extra Flat. This will be a branch product designed to complement the existing brand. While the original Roadkill has found an audience in the 8-14-year-old age category, Roadkill XL-XF will be targeted toward the 12-18-year-old market.
Roadkill XL-XF will be packaged in a sleek 16oz. bottle. The Big Brother brand will utilize the same flavor profiles but will be lightly carbonated to appeal to a slightly older youth market.
Fernhill Beverage, Inc. is positioning Roadkill and Roadkill XL-XF to be the dominant brand in the youth market in 3 to 5 years.
To ensure the constant growth of the brand, Fernhill Beverage is currently seeking a Strategic Partner to help with the marketing and distribution of the brand. The Company is currently speaking with two such beverage companies. Fernhill Beverage, Inc. would like to formally enter into an agreement before Summer 2017.
Fernhill will be excited to update shareholders, vendors and partners as arrangements progress. 2016 has been an exciting year for Fernhill Beverage and Roadkill. The Company expects 2017 to even more exciting.
Fernhill Beverage, Inc.
WE MUST ALL REALIZE THE DIFFERENCE BETWEEN HOPE & EXPECTAION BASED ON GIVEN FACTS.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM